Skip to main content

Drug recalls

Drug recalls from FDA, newest first.
FiltersSort Newest
Agency
Severity
Date
Distributed in

1 recall

1 recall

1 recall

1 recall

1 recall

1 recall

1 recall

1 recall

Glenmark Azelaic Acid Gel

Azelaic Acid Gel, 15%, 50 gram tubes may have abnormal texture or consistency described as grainy, gritty, or sandy.

Moderate riskFDAManufacturing deviation
Glenmark Azelaic Acid Gel

1 recall

1 recall

1 recall

1 recall

1 recall

2 recalls

Amgen Corlanor and Sensipar Tablets

Corlanor (ivabradine) tablets contain a foreign substance, and Sensipar (cinacalcet) Tablets have CGMP deviations.

Moderate riskFDAForeign material
Amgen Corlanor and Sensipar Tablets

1 recall

1 recall

1 recall

1 recall

1 recall

Zydus Erythromycin Tablets

Reason given by FDA: CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit.

Moderate riskFDAImpurity or degradation
Zydus Erythromycin Tablets

1 recall

1 recall

2 recalls

iVIZIA Sterile Lubricant Eye Drops

IVIZIA Sterile Lubricant Eye Drops lack assurance of sterility due to manufacturing deviations.

Moderate riskFDASterility failure
iVIZIA Sterile Lubricant Eye Drops

1 recall

Leading Pharma Furosemide Tablets

CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Moderate riskFDAImpurity or degradation
Leading Pharma Furosemide Tablets

1 recall

1 recall

Cipla Cinacalcet Hydrochloride Tablets

Reason given by FDA: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit.

Moderate riskFDAImpurity or degradation
Cipla Cinacalcet Hydrochloride Tablets

1 recall

1 recall

2 recalls

Harbin Jixianglong Biotech Semaglutide

Reason given by FDA: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution.

Moderate riskFDAManufacturing deviation
Drugs

1 recall

1 recall

1 recall